3 min readBiotech companies have taken center stage during the pandemic of 2020. Between the many vaccine initiatives and even more numerous investments in testing and new Covid-19 therapies, money is flooding into the sector at a record rate. Biotechs raised more than $6 billion in initial public offerings in just the first half of the year….
3 min readHere we go again. As if Covid-19 hadn’t given us all enough to worry about, in March it precipitated a short-lived run on prime money market funds. By the end of the month, approximately $100 billion had drained from institutional prime money market funds—more than 30% of their total assets. For a minute, the 2008…
2 min readTrillions of dollars of support from the Fed have helped keep financial markets open. Trillions more from Congress are supporting consumers. But what will the next phase of the COVID-19 crisis bring? And what does it mean for institutional cash managers? You can find many of the answers in our latest research report, Institutional Cash…
1 min readWe hope you are all safe during this extended period of sheltering at home. Life has changed immeasurably for most of us since February 13, when we published a report on COVID-19 and its impact on liquidity portfolios. Our comments in that report still apply, and on March 31, we provided additional valuable market intelligence…
2 min readAt Capital Advisors Group, we have advised hundreds of early-stage companies on billions of dollars of debt transactions over the past 17 years. We’ve learned that every deal is different, and every company’s capital structure is unique. But one thing never seems to change: even the best-laid plans can go awry. Over the years, we…
2 min readThe World Health Organization has finally given the coronavirus outbreak in China an official name: COVID-19, for “Coronavirus Disease 2019.” Unfortunately, that’s one of the only things we know for sure about the new disease, even as the outbreak extends well into its third month. Consider everything we don’t yet know: Will the draconian quarantine…
3 min readEvery January, we point to three trends cash managers should keep an eye on in the coming year. In 2019, we hit the nail on the head when we highlighted the inverted yield curve, trade wars, and Brexit. Each of those issues kept institutional cash managers busy all year. First, the Fed reversed course with…
2 min readIf you are among the 20 percent of institutional cash managers who don’t have a formal investment policy statement, it may be time to draft one. And if you do have one, December is a good time to dust it off and update it for the coming year. According to the 2019 AFP Liquidity Survey,…
2 min readAfter three interest rate cuts since July, the Fed signaled last month that it finally expects to take a breather, with no more moves for a while. But that only means we have to start wondering what may come next. Will the recent spate of positive economic news prompt the Fed to reverse course and…
2 min readWhen overnight repo rates temporarily rose from 2% to 10% in September, some dismissed the spike as an unfortunate but rare confluence of idiosyncratic circumstances. But if that makes you think the liquidity crunch was a one-time event, think again. Our October research report, Repo Ruckus Reveals Hidden Issues in Liquidity Markets, makes a good…